Reporter and Curator: Dr. Sudipta Saha, Ph.D. There are many considerations in the cancer immunoediting landscape of defense and regulation in the cancer hallmark biology. The cancer hallmark biology in concert with key controls of the HLA compatibility affinity mechanisms are pivotal in architecting a unique patient-centric therapeutic application. Selection of random immune products […]
Original Article: Immunoediting can be a constant defense in the cancer landscape